Spyglass Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of chronic ophthalmic diseases through its innovative drug delivery platform. The company's primary focus is on addressing the challenges of patient compliance and the limitations of traditional eye drop therapies, which are often the standard of care for conditions like glaucoma. Spyglass Pharma's core technology is a proprietary drug-eluting intraocular lens (IOL) platform. This system is designed to be implanted during routine cataract surgery, providing a controlled, long-term release of medication directly into the eye. By automating drug delivery at the source, the company aims to provide a more consistent and effective treatment regimen for patients suffering from glaucoma and ocular hypertension, significantly reducing the burden of daily self-administration. The company's lead product candidate utilizes this platform to deliver bimatoprost, a well-established medication for lowering intraocular pressure, over an extended period. This approach seeks to eliminate the high rates of non-compliance associated with topical drops. Spyglass Pharma is currently advancing its platform through clinical trials to establish the safety and efficacy of its delivery system. Headquartered in Aliso Viejo, California, Spyglass Pharma was co-founded by industry veterans and clinicians with extensive experience in ophthalmology and medical device development. The company is supported by leading venture capital investors and continues to explore the application of its technology to a broader range of ocular conditions beyond its initial focus on glaucoma.
Gross margin measures the amount of revenue that remains after subtracting costs directly associated with production.
The EBITDA margin is a measure of a company's operating profit desconsidering D&A costs as a percentage of its revenue.
The EBIT margin is a measure of a company's operating profit considering D&A costs as a percentage of its revenue.
The net profit margin, or simply net margin, measures how much net income or profit is generated as a percentage of revenue. It is the ratio of net profits to revenues for a company or business segment.
Many companies have a high D&A in relation to the company's operating profit (EBITDA) and although this indicator does not have an effective cash effect, it ends up influencing the accounting net income, so analyzing this relationship can help to understand when D&A has a relevant impact to the company's results.
Shows the amount spent on investments in research and development in relation to the Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
Shows the amount spent on investments in Capex in relation to Net Revenue for the period. The company can use these investments to try to increase its revenue in the future.
Indicates a comparison between investments in fixed/intangible assets and the depreciation and amortization of some company assets. It serves to let managers know that the company's assets are devaluing periodically, and whether CAPEX has followed the same pace or not.
It shows the percentage of operating cash flow that the company uses in Capex (investments in fixed and intangible assets). When your result is greater than 100%, it demonstrates that there are expenses greater than what the company produces in its operations.
It demonstrates the percentage cost of Stock-Based Compensation compared to the company's operating cash flow. In some companies, the OCF is positive because of the SBC, which can lead to an incorrect cash flow analysis.
If the company has a lot of D&A, it helps to see if most of it tends to come from fixed assets. The account can include machinery, equipment, vehicles, buildings, land, office equipment, and furnishings, among other things.
If the company has a lot of D&A, it helps to see if most of it tends to come from Goodwill, that is an intangible asset that accounts for the excess purchase price of another company.
Return on equity (ROE) is the measure of a company's net income divided by its shareholders' equity and is a gauge of a corporation's profitability and how efficiently it generates those profits.
Return on invested capital (ROIC) is a calculation used to assess a company's efficiency in allocating capital to profitable investments. The formula for calculating ROIC involves dividing Net Income by the average of invested capital.
...and much more!